RCM
TDOC icon

Raleigh Capital Management’s Teladoc Health TDOC Stock Holding History

Raleigh Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23
Closed -$200 – 661
2025
Q2 		$200 Hold
23
– – ﹤0.01% 571
2025
Q1 		$183 Buy
+23
New +$233 ﹤0.01% 522
2024
Q2 		– Sell
-3
Closed -$45 – 1018
2024
Q1 		$45 Buy
+3
New +$54 ﹤0.01% 955
2023
Q4 		– Sell
-73
Closed -$1.36K – 1179
2023
Q3 		$1.36K Hold
73
– – ﹤0.01% 806
2023
Q2 		$1.85K Buy
+73
New +$1.84K ﹤0.01% 738

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raleigh Capital Management's TDOC Position: Q3 2025 in Review

Raleigh Capital Management sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 23 shares — an estimated $200 sold.

Raleigh Capital Management first reported a position in TDOC in Q2 2023 and held it in 5 quarters. The position peaked at $1.85K in Q2 2023. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Raleigh Capital Management reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 23 Teladoc Health shares in Q3 2025, an estimated $200.
  • Raleigh Capital Management first reported a position in Teladoc Health in Q2 2023 and held it in 5 quarters.
  • Raleigh Capital Management's Teladoc Health position peaked at $1.85K in Q2 2023.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Raleigh Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.